Background The implication of necroptosis in cardiovascular disease was already
recognized. However, the molecular mechanism of necroptosis has not been extensively …

Aims To examine the association between the burden of cardiometabolic disorders with new-
onset atrial fibrillation (AF) and lifetime risk of AF incidence among men and women …

Background: Atrial fibrillation is the most common clinically significant cardiac arrhythmia,
and it might lead to heart failure, which prolongs the duration of hospitalization and …

Background While current guidelines recommend amiodarone and dronedarone for rhythm
control in patients with atrial fibrillation (AF) and coronary artery disease (CAD), there was …

Background Non-valvular atrial fibrillation (NVAF) is associated with increased stroke in
elderly populations, yet anticoagulant therapy is underutilized. We analyzed clinical …

Background High-sensitivity troponin-T (HS-cTnT) levels are often measured in patients
presenting with atrial fibrillation (AF), with many subjected to unnecessary invasive …

Background: Atrial fibrillation (AF) can often be triggered by an inflammatory substrate.
Perivascular inflammation may be assessed nowadays using coronary computed …

Background A genome-wide association study has recognized C6orf10-BTNL2
polymorphism in coronary artery disease. The goal of this study was to explore the potential …

Background The reported prevalence of patent foramen ovale (PFO) in the general
population is variable. It ranges between 8.6 and 42% according to the population studied …

Atrial fibrillation (AF) is one of the most common sustained tachyarrhythmias worldwide, and
its prevalence is positively correlated with aging. AF not only significantly reduces the quality …